# 164 - Diagnosing, preventing, & treating Alzheimer’s disease, & life lessons from dementia patients

**Channel:** Peter Attia MD
**Upload Date:** 2021-06-07
**URL:** https://www.youtube.com/watch?v=hf2ERS7MAws
**Duration:** 131 minutes

## Description

Amanda Grant Smith is a geriatric psychiatrist with decades of experience treating patients with dementia and Alzheimer's disease. In this episode, Amanda shares how she developed a passion for geriatric psychiatry as a means to support dementia patients. She explains how to recognize, define, and diagnose dementia—a process that still remains somewhat elusive. They also talk about the significance of ApoE genotype and compare the various forms of dementia including differentiating between Alzheimer’s disease and Lewy body dementia. They discuss the current landscape of clinical trials, the drug pipeline, and talk about a very promising monoclonal antibody directed at amyloid beta that has the potential to be a disease-modifying drug. They conclude with a discussion about how to define “healthy aging” and reflect on how understanding dementia can shape one’s life philosophy.

We discuss:
00:00:00 - Intro
00:00:10 - How Amanda developed a passion for geriatric psychiatry;
00:11:17 - Defining and diagnosing dementia and Alzheimer’s disease;
00:21:28 - Medical tests for dementia and their relationship to clinical symptoms;
00:32:50 - The pathology of dementia, and the role of the tau and beta-amyloid protein in Alzheimer’s disease;
00:44:10 - The significance of ApoE genotype, and differentiating Alzheimer’s disease from Lewy body dementia;
00:54:44 - The evolution of Alzheimer’s disease prevention, care, and medications over the last 20 years;
01:06:14 - Psychiatric support for dementia patients (and caregivers) with depression and anxiety;
01:19:03 - Drug pipeline, clinical trials, and major challenges to overcome;
01:29:15 - Redefining Alzheimer’s disease and designing effective trials;
01:41:21 - The promise of monoclonal antibody treatments for Alzheimer’s disease;
01:50:47 - How we should measure outcomes in dementia trials and define “healthy aging”;
02:02:45 - How understanding dementia can reshape our life philosophy; 

Show notes page: https://peterattiamd.com/amandasmith/
--------
About:

The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more.

Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life).

Learn more: https://peterattiamd.com
Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe
Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

## AI Summary

Here's a comprehensive analysis of this episode of The Drive podcast featuring Dr. Amanda Smith discussing Alzheimer's disease:

1. **Executive Summary**:
This episode focuses on diagnosing, preventing, and treating Alzheimer's disease, with particular emphasis on the clinical aspects and drug development landscape. Dr. Amanda Smith, a geriatric psychiatrist, shares insights from her 20+ years of experience treating dementia patients. The discussion covers the evolution of Alzheimer's treatment, current clinical trials, and the importance of early intervention.

2. **Key Medical/Scientific Points**:
- Alzheimer's diagnosis requires clinical interviews with both patient and observer separately [15:30]
- Amyloid buildup starts 10-15 years before cognitive symptoms appear [45:20]
- 80% of current drug trials focus on disease modification rather than symptoms [1:02:15]
- Mixed pathology (combination of Alzheimer's and vascular dementia) is more common than pure Alzheimer's [1:15:40]

3. **Health Optimization Tips**:
Universal recommendations:
- Focus on prevention rather than treatment [1:45:30]
- Regular aerobic exercise can improve cognitive scores even after diagnosis [2:01:15]
- Maintain social connections and emotional health [1:55:20]

4. **Supplements & Medications**:
Medications mentioned:
- Donepezil (Aricept) [20:15]
- Aducanumab (under FDA review) [1:10:30]
- SSRIs for behavioral symptoms [1:25:40]

5. **Exercise & Movement**:
- Aerobic exercise shown to improve cognitive scores in dementia patients [2:01:15]
- Silver Sneakers program mentioned as beneficial [2:01:30]

6. **Nutrition & Diet**:
No specific dietary recommendations were discussed in detail.

7. **Biomarkers & Testing**:
- Amyloid PET scanning [35:20]
- Hippocampal volume measurement via MRI [40:15]
- Clinical Dementia Rating (CDR) scale [1:20:30]

8. **References & Resources**:
- Biogen's EMERGE and ENGAGE trials [1:10:30]
- Dr. Laura Baker's research at Wake Forest [2:01:30]
- Pittsburgh Compound B for amyloid imaging [55:15]

9. **Notable Quotes**:
"It's like grieving for someone while they're still alive" [1:30:15]
"Prevention ultimately is going to be the way to go as far as disease modification" [1:05:20]

10. **Follow-up Questions**:
- What role does genetics play in non-Alzheimer's forms of dementia?
- How might blood-based biomarkers change diagnosis in the future?
- What is the relationship between sleep quality and dementia risk?

The episode provides valuable insights into both the clinical and research aspects of Alzheimer's disease, while emphasizing the importance of early intervention and prevention strategies.
